Fundación Epic
Clinical trials sponsored by Fundación Epic, explained in plain language.
-
Stenting unstable plaques: a new way to prevent second heart attacks?
Disease control OngoingThis study looks at 600 people who had a major heart attack and have other narrowings in their heart arteries that are not severe but look unstable. Half will get a stent plus medication, and half will get medication alone. The goal is to see if stenting these unstable plaques re…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Heart device under watch: new study tracks Real-World safety
Disease control OngoingThis study monitors the safety and performance of a medical device called Sequent Please Neo, used to treat blocked heart arteries. About 2,028 people receiving the device as part of their routine care will be followed. Researchers will track major heart problems like heart attac…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New balloon treatment may shorten blood thinner use for heart patients
Disease control OngoingThis study is testing a paclitaxel-coated balloon to open small coronary arteries in people with heart disease who also have a high risk of bleeding. About 501 participants will receive the balloon treatment and then take blood thinners for either the standard duration or just 7 …
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New stent shows promise for quicker heart vessel healing
Disease control OngoingThis study tests a new drug-coated heart stent (VIVO ISAR) against a standard one (XIENCE Skypoint) in 40 people with coronary artery disease. Each patient receives both stents in different blocked arteries, and doctors use a special camera to check healing after one month. The g…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New heart stent under Real-World watch: will it hold up?
Disease control OngoingThis study is tracking 400 people with coronary artery disease who received the ihtDEStiny drug-eluting stent during a routine procedure to open blocked heart arteries. Researchers are monitoring how well the stent works over time, including rates of heart attacks, repeat procedu…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Blood test may cut bleeding risk for heart patients on strong meds
Disease control OngoingThis study tests whether a blood test can help doctors safely lower the dose of strong blood thinners (P2Y12 inhibitors) in people who recently had a heart attack or stent. The goal is to reduce bleeding complications without raising the risk of another heart attack or stroke. Ab…
Phase: PHASE4 • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New study aims to sharpen diagnosis of dangerous heart blockages
Diagnosis OngoingThis study compares two imaging techniques, OCT and IVUS, used to evaluate blockages in a key heart artery. Researchers want to see if OCT can better identify which blockages need treatment. The study involves 153 adults with moderate blockages and will track their heart health o…
Sponsor: Fundación EPIC • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Heart study asks: is a second look inside arteries worth it?
Knowledge-focused OngoingThis study follows 400 people who had a stent placed in the left main coronary artery. Half get a routine angiogram 6 months later, while the other half have only clinical follow-up. Researchers want to see if the extra imaging reduces the chance of death, heart attack, or stroke…
Phase: NA • Sponsor: Fundación EPIC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Real-world heart procedure blood thinner patterns under the microscope
Knowledge-focused OngoingThis study tracks how doctors in Spain use injectable blood thinners (cangrelor or GPIs) during heart procedures like stent placement. It includes 717 patients and will look at short-term outcomes like death, heart attack, stroke, and bleeding within 48 hours. The goal is to unde…
Sponsor: Fundación EPIC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Heart patients could go home in 24 hours after valve procedure
Knowledge-focused OngoingThis study looks at whether people who get a new heart valve through a tube in their leg (TAVI) can safely go home just 24 hours later. Researchers will track 585 patients for complications like stroke, heart attack, or need for a pacemaker. The goal is to see if early discharge …
Sponsor: Fundación EPIC • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC